Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for DLH Holdings Corp. (DLHC:NASDAQ), powered by AI.
DLH Holdings Corp. is currently trading at $5.47. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for DLH Holdings Corp. on Alpha Lenz.
DLH Holdings Corp.'s P/E ratio is 57.8.
“DLH Holdings Corp. trades at a P/E of 57.8 (premium valuation) with modest ROE of 1.2%.”
Ask for details →DLH Holdings Corp. is a comprehensive provider of technology-enabled healthcare and human services, primarily serving the federal government. The company's core focus lies in delivering mission-critical healthcare services, solutions, and delivery systems that significantly enhance the collaborative efforts of federal agencies in healthcare management, scientific research, and advanced technology systems. DLH operates within pivotal sectors such as healthcare, human services, and defense, offering an array of services including program management, medical logistics, clinical research, and software solutions. Headquartered in Atlanta, Georgia, DLH Holdings Corp. plays an essential role by supporting national health preparedness, veterans’ health, and military readiness initiatives, thereby ensuring quality care and efficiency. With contracts spanning various governmental departments, the company stands as a key player in optimizing federal health and social services infrastructure. By leveraging advanced data analytics and forward-thinking methodologies, DLH Holdings Corp. contributes to the improvement of healthcare outcomes and operational efficiencies, solidifying its position as an integral component of the U.S. government's service delivery ecosystem.
“DLH Holdings Corp. trades at a P/E of 57.8 (premium valuation) with modest ROE of 1.2%.”
Ask for details →DLH Holdings Corp. (ticker: DLHC) is a company listed on NASDAQ in the Industrials sector (Specialty Business Services). It has approximately 2,800 employees. Market cap is $79M.
The current price is $5.47 with a P/E ratio of 57.78x and P/B of 0.7x.
ROE is 1.22% and operating margin is 4.87%. Annual revenue is $344M.